The most common mutations associated with SCLC transformation included TP53, RB1 and PIK3CA. Small experiences, applying complementary testing of tumour tissue and liquid biopsy, showed how ctDNA analysis could suggest neuroendocrine evolution, when typical SCLC-associated genetic alterations become detectable [99, 100]. The gene discussed is TP53; the disease is small cell lung carcinoma.